Tag: advanced accelerator applications
January 29, 2018
Novartis Advanced Accelerator Applications Receives FDA Approval for Lutathera
Novartis (NYSE: NVS) announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US Food and Drug... January 26, 2018
Advanced Accelerator Applications Receives US FDA Approval for LUTATHERA
Advanced Accelerator Applications (NASDAQ:AAAP) a Novartis company and leader in nuclear medicine theragnostics, today announced that it has received US Food... January 22, 2018
Novartis completes tender offer for Advanced Accelerator Applications S.A. and commencement of subsequent offering period
Novartis (NYSE: NVS) announced the successful completion of the tender offer by its subsidiary, Novartis Groupe France S.A., to purchase... October 6, 2016
Advanced Accelerator Applications Announces Pricing of $150 Million Public Offering of American Depositary Shares
Advanced Accelerator Applications, an international specialist in Molecular Nuclear Medicine, today announced the pricing of an underwritten public offering of...
September 23, 2016
Life Science Sector Responds Favorably to US Federal Reserve Decision
The US Federal Reserve did not raise interest rates on September 21—and the life science sector, like other markets, has... September 22, 2016
EMA Prematurely Announced Opinion on SomaKit TOC® Kit Application
Advanced Accelerator Applications (NASDAQ:AAAP) announced that the European Medicines Agency (EMA) prematurely notified the public and the company of its... May 18, 2016